| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |